6 - 12 month conceptual target $6.00 - 12.00 per share

AS coronavirus spreads, conceptual value of ZNO nanotech IP technology soars. Assume that ZNO pushes sales to US$5.0M per month within next 6 months and then ramps to US$10.0M per month within 12 months. In terms of the amount of product required to fight this virus on a global scale, we are still talking a mere pittance.

Assume that EBITDA is 50% of sales then we get free cash flow of US$30M - US$60M. On a conceptual basis valuation is 20x (30x??) free cash flow for US$600M to $US$1,200,000M.

Current valuation is A$231M / US$156M at A$1.54 per share. Conceptual upside is 3.9x - 7.7x current price of $6.00 - 12.00 per share.

Assuming that we have a global "market leading" technology that generates significant global sales then annualized sales of $60.0M may be considered a pittance. My forecast of first price target of $1.50 has been met. IMHO we will now go up in steps to reach $3.00 and then $6.00.

Next major catalyst is independent verification of the Zoono molecule to destroy coronavirus. This validation may serve as a launch point for new sales contracts. AS stature of IP platform and name recognition grows, market penetration will grow rapidly, especially into other applications.